Virtu Financial LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 216 filers reported holding NEKTAR THERAPEUTICS in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2023$8
-78.4%
13,675
-16.6%
0.00%
-80.0%
Q4 2022$37
-100.0%
16,394
-29.5%
0.01%
-89.8%
Q4 2019$502,000
+19.8%
23,260
+97.5%
0.05%
+96.0%
Q2 2019$419,000
+46.0%
11,780
-48.6%
0.02%
-3.8%
Q2 2015$287,000
+50.3%
22,907
+44.6%
0.03%
+30.0%
Q3 2014$191,00015,8400.02%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2022
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
Virtus ETF Advisers LLC 72,018$230,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders